Indication for index EGD (Top 5) | |
Dyspepsia or gastroesophageal reflux, n (%) | 93 (27.1%) |
Abdominal pain, n (%) | 88 (25.7%) |
Iron deficiency anemia, n (%) | 80 (23.4%) |
Gastrointestinal bleeding, n (%) | 52 (15.2%) |
Weight loss, n (%) | 36 (10.5%) |
Findings at index EGD | |
Low-grade dysplasia at index EGD, n (%)a | 1 (0.3%) |
High-grade dysplasia at index EGD, n (%) | 0 (0.0%) |
Multifocal GIM at index EGD, n (%)b | 53 (15.5%) |
GAC at index EGD, n (%) | 18 (5.3%) |
H. pylori on biopsy, n (%) | 97 (28.4%) |
Recommended interval for repeat EGD for GIM surveillance | |
EGD not recommended | 202 (59%) |
1–3 months | 9 (2.6%) |
3–6 months | 12 (3.5%) |
1 year | 33 (9.6%) |
2–3 years | 83 (24.2%) |
5 years | 2 (0.5%) |
Patients with repeat EGD with biopsies, n (%) | 81 (23.6%) |
Months from index to repeat EGD, median (IQR) | 13 (3–29) |
Months from index EGD to last clinic follow-up, median (IQR) | 14.7 (2.2–42.7) |
Findings at repeat EGD | |
Low-grade dysplasia at repeat EGD, n (%) | 0 (0) |
High-grade dysplasia at repeat EGD, n (%) | 0 (0) |
Multifocal GIM at repeat EGD not found at index EGD, n (%)c | 10 (14%) |
GAC at repeat EGD not found at index EGD, n (%) | 0 (0) |